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Abstract 
The oxytocin (OT) and dopamine (DA) systems are highly intertwined and have been implicated 
in a number of similar behaviors, particularly social, sexual, and maternal behaviors. However, 
the direct pharmacological effect of OT administration on the DA system is yet to be determined. 
Additionally, although nasal OT is the primary route of administration in human research, it is 
rarely used in animal studies, with researchers often relying on other routes for systemic OT 
administration (e.g., intraperitoneal injection). The present study aims to fill this gap in the 
literature by examining the effect of nasal OT on the DA system using fast-scan cyclic 
voltammetry. Specifically, stimulated DA release in the nucleus accumbens was measured before 
and after nasal OT administration in female rats. Because the peripartum period is rife with 
neuroendocrine changes, both virgin and postpartum animals were used to examine how 
pregnancy affects OT-DA interactions. However, no effect of OT was found, which is 
inconsistent with past research and suggests an indirect mechanism by which OT affects DA and 
DA-driven behaviors. Parity status was found to have a significant effect on baseline levels of 
evoked DA release, with postpartum animals showing larger concentrations of DA compared to 
virgin females. This corroborates past studies finding alterations in the DAergic system 
following pregnancy. 
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Electrically Evoked Dopamine Release in Virgin and Postpartum Rats:  
Lack of Modulation by Nasal Oxytocin 
Our drive to form social bonds between friends, family, and romantic partners relies on a 
complex neural circuitry, partially involving the oxytocin (OT) and dopamine (DA) systems. 
These two neurochemicals are highly involved in motivational behavior, and their interaction has 
been implicated in social-cognitive processing. However, the details of this interaction are still 
under investigation, and OT’s effect on motivational behavior (and the DAergic system by 
extension) seems to vary depending on the context. Although DA appears to be involved in all 
types of motivational cues, OT seems to enhance the salience of social cues in particular. It has 
been hypothesized that the dysregulation of these two systems can lead to maladaptive behaviors, 
such as drug abuse and child neglect, where naturally motivational social cues are devalued and 
drug cues are overvalued. In this paper, I will first provide a brief overview of the OT and DA 
systems, their circuitry, and the behaviors in which they are involved, followed by a description 
of how the two systems are connected. Next, I will relate animal findings to human research and 
provide a brief introduction to fast-scan cyclic voltammetry, the electrochemical technique I will 
use to measure DA release. Finally, I will introduce my general plan for investigating the 
interaction of the OT and DA systems.  
Oxytocin and Dopamine: Circuitry and Interaction 
OT exerts a wide range of effects, both behavioral and biological, likely due to its ability 
to act as both a neurotransmitter in the nervous system and a hormone throughout the body. On a 
physiological level, it plays a fundamental role in lactation, erection, ejaculation, and triggering 
labor (Gimpl, Fahrenholz, & Gene, 2001). In the central nervous system, OT has been implicated 
in a number of complex behaviors, such as social behavior, sexual behavior, and maternal 
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caregiving (for review, see Lee, Macbeth, Pagani, & Scott Young, 2009). This range of effects 
may be due to OT’s widespread presence throughout the brain. OT is primarily synthesized in 
the paraventricular nucleus (PVN) and supraoptic nucleus (SON) of the hypothalamus (Gimpl et 
al., 2001). From there, the SON primarily projects to the pituitary to release OT into the 
bloodstream, but the PVN has a wide range of projections, including the olfactory bulb, medial 
preoptic area (MPOA), nucleus accumbens (NAc), amygdala, hippocampus, and ventral 
tegmental area (VTA) (Rutherford, Williams, Moy, Mayes, & Johns, 2011).  
OT has been linked with a number of neurochemical systems, including serotonin 
(Marazziti et al., 2012), nitric oxide (da Silva, Cedraz-Mercez, & Varanda, 2014), and GABA 
(Lonstein, Maguire, Meinlschmidt, & Neumann, 2014). Additionally, OT and DA have been 
found to share some circuitry and are involved in similar behaviors. DA plays a fundamental role 
in motivational behaviors, including reward learning (Day, Roitman, Wightman, & Carelli, 
2007), drug administration (Di Chiara et al., 2004), social and sexual behavior (Brom, Both, 
Laan, Everaerd, & Spinhoven, 2014; Insel, 2003), and maternal caregiving (Love, 2014). A 
major source of DA is the VTA, which projects to a number of forebrain structures, including the 
olfactory tubercle, prefrontal cortex, and NAc, the last of which being the main focus of the 
present study. The NAc has been strongly implicated in motivational behavior, and the amount 
of effort an animal will exert to achieve a reward is dependent on extracellular DA in the NAc 
(for review, see Salamone, Correa, Farrar, & Mingote, 2007). In addition, NAc DA transients, or 
burst firing of DA neurons, are thought to be important in cue-reward associations. Through the 
course of Pavlovian conditioning, where an unconditioned stimulus (e.g., a light) is presented 
before an unconditioned reward (e.g., a food pellet), DA transients shift from occurring after the 
reward to eventually occurring after the stimulus, suggesting their importance in learning the 
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predictive value of the cue (Day et al., 2007). NAc DA also plays a fundamental role in maternal 
behavior, especially appetitive behaviors (goal-directed behaviors), such as pup retrieval, which 
is impaired after administration of a DA antagonist to the NAc (Keer & Stern, 1999). DA release 
in the NAc has also been found during pup licking/grooming (Champagne et al., 2004) and in 
response to pup cues (cries and odors) in hormonally primed virgin females (Afonso, Shams, Jin, 
& Fleming, 2013). 
The DAergic and OTergic systems are interrelated in a number of ways. The PVN 
projects to both the VTA and the NAc, and the MPOA sends strong projections to the VTA (for 
review, see Numan & Stolzenberg, 2009). Both the VTA and NAc express OT receptors, and 
many OT cells in the MPOA, PVN, and SON express DA receptors in return, indicating a 
reciprocal relationship between the two systems (Baskerville, Allard, Wayman, & Douglas, 
2009; Vaccari, Lolait, & Ostrowski, 1998). OT receptors are not found on the DAergic cells in 
the VTA, however, indicating that their relationship may be indirect (Yoshida et al., 2009). Even 
so, their neurobiological interaction is plausible, given that both neurochemicals have been 
implicated in similar behaviors, including social, sexual, and maternal behavior. 
OT’s influence on the DA systems can be facilitatory or inhibitory, depending on the 
context. For example, infusing DA into the subthalamic nucleus of the hypothalamus enhanced 
conditioned place preference, but adding OT abolished this effect (Baracz & Cornish, 2013). 
This suggests that OT in this area inhibits the motivating effect of DA in the conditioned place 
preference task. Additionally, OT has been found to suppress some effects of drugs of abuse (for 
review, see McGregor & Bowen, 2012). Peripheral OT administration has been shown to reduce 
the locomotor effects of methamphetamine and cocaine, both of which increase DA release and 
block DA reuptake (Carson et al., 2010; Kovàcs, Sarnyai, Barbarczi, Szabó, & Telegdy, 1990). 
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These effects may result from OT’s inhibitory effect on the DA system, given that OT reduced 
methamphetamine-induced activity in the NAc (Carson et al., 2010) and inhibited the increased 
DA utilization found after cocaine administration (Kovàcs et al., 1990). 
However, in other contexts, OT appears to exert an excitatory effect on the DA system 
and its related behaviors. Although adding OT diminishes a DA-induced conditioned place 
preference, the same effect is not found in a conditioned partner preference task (Triana-Del Rio 
et al., 2015). In this experiment, male rats were co-housed with a same sex partner and received 
saline, a DA receptor agonist, or a combination of a DA receptor agonist and OT. When later 
presented with either their same-sex partner or a sexually receptive female, both the DA and 
DA/OT animals preferred their male partner, whereas saline animals preferred the female, 
suggesting an alteration in either social or sexual behavior. In this case, adding OT did not 
eliminate the partner preference like it did for conditioned place preference. In terms of maternal 
behavior, administering OT to virgin female rats increases pup-directed behaviors, such as 
licking, nursing, pup retrieval, and nest-building, all behaviors that rely on DA (Fahrbach, 1984). 
Infusing an OT antagonist into the VTA of postpartum dams reduced DA release in the NAc 
during pup interaction, suggesting that pup-induced DA release is dependent on OT (Shahrokh, 
Zhang, Diorio, Gratton, & Meaney, 2010).  
It seems as though OT’s influence on DA depends on the type of reward involved, 
possibly due to parallel brain systems used for processing non-social and social rewards. Either 
reward system can be strengthened by exciting the DAergic system, either by administering a 
DA agonist or drugs of abuse that act on the DA system, like methamphetamine and cocaine. 
However, the OTergic system appears to devalue non-social rewards and increase the salience of 
social cues. When non-social rewards are involved, such as a conditioned place preference or 
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drugs of abuse, OT appears to have an inhibitory effect on the DA system and the behaviors 
involved. However, for social and/or sexual rewards, such as a partner preference and maternal 
behavior, OT appears to exert an excitatory effect on the DA system. Although there is a wealth 
of research investigating OT-DA interactions in awake, behaving animals, much less is known 
about the basic pharmacological effect of exogenous OT on the DA system.  
Oxytocin Administration in Animal and Human Studies 
Animal studies tend to use infusion or injection to administer OT, but these techniques 
are too invasive for human studies. Instead, intranasal OT has been used widely in the human 
literature to modulate social functioning. Intranasal OT may increase the salience of socially 
relevant cues, including positively and negatively charged faces (Groppe et al., 2013), infant 
laughter (Riem et al., 2012), and both infant and sexual images (Gregory, Cheng, Rupp, 
Sengelaub, & Heiman, 2015). Additionally, intranasal OT has been found to improve symptoms 
of conditions that impair social functioning, such as schizophrenia (Feifel et al., 2010) and 
autism (Domes et al., 2013; Guastella et al., 2010). Finally, as mentioned earlier, intranasal OT 
has been proposed as a possible treatment for drug addiction, due to its ability to reduce the 
salience of drug cues (for review, see McGregor & Bowen, 2012). 
Because intranasal OT is so widely used in human studies, its use in animal studies would 
allow for a more accurate translation of animal findings to human research. Additionally, 
intranasal administration has some practical benefits that other administration routes lack. 
Intranasal administration allows OT to enter the central nervous system through the olfactory 
epithelium, largely bypassing the blood-brain barrier, which can prevent as much as 99.998% of 
subcutaneously administered OT from reaching the central nervous system (Mens, Witter, & Van 
Wimersma Greidanus, 1983). OT is also vulnerable to enzymatic degradation in the bloodstream 
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of rats, where it has only a 2 minute half-life. However, in the cerebrospinal fluid, its half-life 
can be extended to up to 19 minutes (Mens et al., 1983). For these reasons, intranasal OT may be 
more effective in elevating central OT levels for extended periods of time.  
Although it is not commonly used in animal studies, intranasal (in non-human primates) 
and nasal (in rodents) OT appears to exert similar effects as other routes of administration. As 
with injections and intracerebral infusions, nasal OT has been found to increase central and 
peripheral OT levels in rats and mice, although the exact route by which this occurs is unclear 
(Neumann, Maloumby, Beiderbeck, Lukas, & Landgraf, 2013). Research on the behavioral 
effects of intranasal OT in animals appears to mirror findings from the human literature. 
Intranasally applied OT reduced the hypothalamic-pituitary-adrenal axis stress response to social 
isolation in squirrel monkeys (Parker, Buckmaster, Schatzberg, & Lyons, 2005) and facilitated 
social bonding in marmoset monkeys (Smith, Ågmo, Birnie, & French, 2010). However, little 
research has been performed investigating how intranasal or nasal OT affects the DA systems in 
animals. 
Fast Scan Cyclic Voltammetry 
The present study examines how nasal OT affects NAc DA release, using fast-scan cyclic 
voltammetry (FSCV). FSCV allows for a higher spatial and temporal resolution than other 
techniques such as microdialysis. This electrochemical technique involves applying a range of 
electrical potentials to an electrode placed in the brain region of interest; as the chemicals around 
the electrode undergo oxidation-reduction reactions at the various potentials, the changes in 
current are measured to deduce the concentration of specific chemicals (Robinson, Venton, 
Heien, & Wightman, 2003; Robinson & Wightman, 2007). For DA, the waveform of the applied 
potential is typically triangular and increases from -0.4V to +1.3V and back to -0.4V, repeating 
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at 10 Hz throughout a recording session. The applied potential creates a large background 
current, which can be subtracted from the recorded voltammograms to reveal smaller changes in 
current. Because compounds have specific potentials at which they oxidize or reduce, the 
background-subtracted voltammogram can be identified as a specific molecule, allowing for 
measurement of the chemical of interest. Specifically, DA oxidizes to its ortho-quinone at 
approximately 0.6 V and the ortho-quinone reduces back to DA at approximately -0.2 V 
(Robinson & Wightman, 2007). This exact pattern is not shared with other compounds such as 
serotonin or nitric oxide. However, norepinephrine oxidizes and reduces at the same potentials as 
DA, making it important to consider the anatomical position of the electrode when identifying 
norepinephrine and DA using voltammetry (Robinson & Wightman, 2007). 
FSCV can be used in freely moving rats to measure real-time neurochemical changes as 
the animal behaves and interacts with its environment, but it can also be used in anesthetized 
animals to answer pharmacological questions. To measure DA release in the NAc in anesthetized 
animals, a stimulating current is applied to the VTA and the resulting DA release is measured at 
its terminals in the NAc. In this way, the neurobiological effects of a pharmacological agent 
(such as OT) can be isolated from its behavioral components and environmental influences can 
be eliminated.  
Project Plan 
To investigate OT’s interactions with the DA system, electrically stimulated DA release 
in the NAc was measured before and after nasal OT administration (or its vehicle as a control). 
Virgin females and postpartum dams were used to determine whether pregnancy alters OT’s 
effect on NAc DA, given that the neuroendocrine system, OT included, undergoes a wide array 
of changes throughout the peripartum period (Neumann, 2003). We hypothesize that nasal OT 
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increases DA release in the NAc. Past studies have found that infusing OT into the VTA 
increases DA release in the NAc of awake animals, in both male and female animals (Melis et 
al., 2007; Shahrokh et al., 2010), but whether this occurs after nasal OT in anesthetized animals, 
as well as postpartum dams, is yet to be established.  
Methods 
Animals 
Virgin female (250-430g) Sprague-Dawley rats (Charles River, Raleigh, NC) were pair 
housed on a 12-hour light-dark schedule. Female rats to be bred were single housed on a reverse 
12-hour light-dark cycle (lights off at 0900) for a 2-week habituation period, after which they 
were housed with breeder males. Gestation day (GD) 0 was designated as the day a sperm plug 
was found. Pregnant females were weighed daily throughout their gestation. On GD 1, females 
were returned to single housing and kept under the reverse light-dark cycle until GD 7, when 
they were moved to a room with regular light cycle (lights on at 0700) for the rest of the 
experiment. This procedure generally causes dams to deliver during daytime hours on GD 21 
(Mayer & Rosenblatt, 1998). On delivery day (postpartum day (PPD) 0), litters were culled to 4 
males and 4 females. The final weights of postpartum animals ranged from 213 to 323g. All rats 
received water and food ad libitum. All procedures were conducted under federal and 
institutional animal care and use committee guidelines for humane treatment. 
Surgery 
Virgin females underwent surgery at least one week after arriving in the animal facility, and 
postpartum dams underwent surgery on PPD 1. Litters from dams were euthanized 30 minutes 
prior to the dams’ anesthesia administration to remain consistent with past studies from the Johns 
lab, in which dams were separated from their pups for 30 minutes before the experiment was 
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conducted. Rats were anesthetized (1.5g/kg urethane, i.p.) and placed in a stereotaxic frame. 
Electrodes were implanted as previously described (Shnitko & Robinson, 2014); electrode 
placements (from bregma) were -5.0mm and ML -1.2mm for the stimulating electrode and AP 
+1.7mm and ML +1.8mm for the carbon fiber electrode. The stimulating electrode (bipolar, 
parallel, stainless steel, 0.2 mm diameter/tip; Plastics One, Roanoke, VA) was initially placed in 
the VTA at DV -8.0mm, and the carbon fiber electrode (length 60-115μm) was initially placed in 
the NAc core DV -6.0mm. Both electrodes were lowered to optimize DA signal, with final 
placements ranging from -8.1mm to -9.0mm for the stimulating electrode and -6.0mm to -6.3mm 
for the carbon fiber electrode. A reference electrode (Ag/AgCl) was placed in the left hemisphere 
and secured with a stainless-steel screw and dental cement.  
Voltammetry and Experimental Procedure 
 The applied potential was ramped from -0.4 V to +1.3 V and back to -0.4 V every 100 
ms. A stimulating current was applied to the VTA (24 biphasic square-wave pulses, 2 ms per 
phase, 260.3 – 304 μA, 60 Hz); the stimulation current was adjusted to optimize the DA signal 
and varied from animal to animal. Three evoked signals, collected 5 minutes apart, were 
measured before OT or vehicle administration to determine the animal’s baseline level of 
stimulated DA release. Following nasal treatment (10 μL per nostril of 1 mg/ml OT or its 
vehicle), 12 evoked signals were collected five minutes apart, totaling an hour of voltammetric 
recording. This time frame was chosen because brain OT levels peak at approximately 30 – 60 
minutes after either intraperitoneal or nasal OT administration (Neumann et al., 2013). In order 
to convert current to DA concentration, electrodes were calibrated in vitro post-experiment, as 
previously described (Robinson & Howard, 2009). In short, current was recorded from each 
electrode while submerged in a flow of TRIS buffer and then in a buffer with a known 
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concentration of DA (1μM). Electrodes from 10 animals were preserved for calibration, and 
calibration factors (μM/nA) for the remaining electrodes were estimated from these calculations.  
Drug Preparation 
 1mg/mL OT solution was prepared by dissolving synthetic OT (Bachem Americas, Inc., 
Torrance, CA) in a saline and 0.1% acetic acid solution, as OT requires a mildly acidic 
environment in order to dissolve. Aliquots were kept frozen at -80°C until the time of the 
experiment.  
Analysis 
Voltammetric analysis.  Before analysis, data files were renamed in order to mask the time 
point at which the file was taken (i.e., before or after drug administration) to reduce researcher 
bias during analysis. Voltammetric data was analyzed as previously described (Shnitko & 
Robinson, 2014). DA was identified in the voltammetric current using color plots and cyclic 
voltammograms. An average background voltammogram was taken from the 5 seconds 
preceding stimulation and was subtracted from voltammograms taken during and after 
stimulation to create background-subtracted voltammograms. No 2D smoothing was applied to 
the data. Current-versus-time traces were used to determine peak current (nA) for each 
stimulation. Calibration factors collected post-experiment were used to convert peak current to 
peak concentration (μM), which will be referred to as [DA]max. 
Dopamine signal modeling. To investigate whether DA release and uptake differed 
between virgin and postpartum groups, DA release and clearance in baseline recordings were 
examined as previously described (Shnitko, Spear, & Robinson, 2015) using the Michaelis-
Menten kinetic equation (Wu, Reith, Wightman, Kawagoe, & Garris, 2001). This equation 
models electrically stimulated DA release as a function of the concentration of DA released per 
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pulse of stimulation ([DA]p, nM), the frequency of electrical stimulation (f, Hz), the velocity of 
DA transporters (Vmax, nM/sec), and the affinity of those transporters (Km, nM). For each 
baseline recording, a model of the current-versus-time plot was generated using this equation. Km 
was held at 200nM and [DA]p and Vmax were modified until the model resembled the 
experimental data, with a correlation coefficient of at least 0.9. For each animal, average [DA]p 
and Vmax measurements were calculated from the three baseline files and were then compared 
between virgin and postpartum groups, collapsing across nasal treatment groups. 
Statistical analysis. To examine maximum evoked DA concentration over the course of the 
experiment, each rat’s 15 data points were condensed to five time points by averaging [DA]max 
from three consecutive files at a time, leaving each rat with five total measurements: one baseline 
measurement and four post-administration measurements. To examine how postpartum status 
affects the concentration of DA release, concentration of DA released per pulse of stimulation, 
and the velocity of DA transporters, three Mann-Whitney Rank Sum tests were performed (due 
to non-equal variance between groups), comparing [DA]max, [DA]p, and Vmax between virgin and 
postpartum groups, collapsing across nasal treatment groups. 
To examine changes in DA signal following OT treatment, the data for each rat was 
normalized to baseline by calculating the percent change from baseline for each of the four post-
administration measurements. A two-way repeated measures ANOVA was performed with 
percent change from baseline as the dependent variable, group as a between-subjects factor 
(OT/virgin, vehicle/virgin, OT/postpartum, vehicle/postpartum), and time as within-subjects 
factor (four post-administration measurements). 
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Results 
Baseline Dopamine 
 To determine how parity affects evoked DA release, we examined [DA]max at baseline in 
virgin animals (n=6) and postpartum dams (n=7), collapsing across nasal treatment groups. Of 
the postpartum dams, five were run the day after delivery (PPD 1), and two were run on PPD 3. 
All animals included in this analysis received 2.24-2.26V stimulation (289-304μA); two animals 
(both OT-treated virgin females) received 2.2V (260.3μA) stimulation and were removed from 
this analysis. The baseline concentration of evoked DA release in postpartum dams (Mdn=0.941 
μM) was over five times larger than virgin females (Mdn=0.123 μM), as shown in Figure 1. This 
difference was statistically significant (Mann-Whitney U=2.0, p=0.005). As shown in Figure 2, 
[DA]p  also varied significantly between virgin and postpartum groups as well (Mann-Whitney 
U=2.0, p=0.008), with postpartum dams releasing more DA per stimulation pulse (Mdn=62 nM) 
than virgin animals (Mdn=8.833 nM). Also illustrated in Figure 2, although Vmax did not vary 
significantly between parity groups, there was a trend toward significance (Mann-Whitney 
U=7.0, p=0.051), with postpartum animals showing reduced velocity of DA transport 
(Mdn=1600 nM/sec) compared to virgins (Mdn=826.667 nM/sec). Figure 3 shows color plots 
from representative animals to illustrate these differences. 
Change from Baseline 
 To examine the effect of nasal administration of OT or its vehicle on DA release, the 
percent change from baseline was determined for each 15 minute averaged epoch. Regardless of 
nasal treatment group or parity status, there was no change from baseline, as shown in Figure 4. 
A two-way repeated measures ANOVA found no effect of group [F(3, 30) = 0.0969, p=0.960] or 
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time [F(3, 30) = 0.587, p=0.628] on percent change from baseline, nor was there an interaction of 
group and time [F(9, 30) = 0.361, p=0.945]. 
Discussion 
Nasal Oxytocin Does Not Modulate Stimulated Phasic Dopamine Release 
Although the interactive role of OT and DA in behavior is under thorough investigation, 
the direct pharmacological effect of OT administration on the DA system is relatively unclear. In 
the present study, the effect of nasal OT administration on stimulated DA release in the NAc was 
examined. Although we predicted that OT would increase DA release, no effect was found. This 
runs in contrast to the behavioral studies upon which this project was designed, which found that 
OT exerted either a facilitatory or inhibitory effect on the DA system, depending on the 
behavioral context under investigation.  
We anticipated a simple, direct effect of nasal OT on DA release, but it appears that the 
process may be more complex. Indeed, even the basic assumption that OT directly facilitates 
social behavior has been questioned in the literature. Though OT is often defined as the “moral 
molecule” or the “hug hormone,” its effects on behavior may be less than straightforward. Many 
behavioral studies tend to consider only a top-down effect of OT on social behavior; i.e., changes 
in behavior are due to OT’s direct effect on the central nervous system. However, OT’s effect on 
peripheral organs is not to be dismissed, and bottom-up processes should be taken into 
consideration. Beyond the central nervous system, OT receptors are present throughout the body, 
including the heart and cardiovascular system, the kidneys, mammary tissues, and the 
reproductive tract of both males and females, all of which could be affected by systemic OT 
administration (Gimpl et al., 2001). Indeed, OT administration has been known to reduce body 
temperature and heart rate, which may contribute to behavioral effects (Hicks et al., 2014). 
17 
NASAL OXYTOCIN AND DOPAMINE 
Additionally, organs in the periphery may influence OT release in the nervous system, as both 
the heart (van Lieshout, Wieling, Karemaker, & Eckberg, 1991) and the kidneys (Ciriello, 1998) 
have afferent projections to the hypothalamus. Vaginocervical stimulation has been found to 
increase OT release in the olfactory bulb (OB) and enhance social recognition memory 
(Larrazolo-López et al., 2008), so it is entirely possible that systemic OT’s effect on organs can 
indirectly influence central nervous system activity and behavior by extension.  
In addition to OT’s peripheral effects, OT has been found to exert an anxiolytic effect 
(Yoshida et al., 2009). Like its effects on social behavior, this reduction in anxiety may be due to 
the complex interaction of its central and peripheral effects. It is also important to consider 
whether OT’s social behavior effects may be partly due to its anxiolytic nature (for review, see 
Churchland & Winkielman, 2012). As Churchland and Winkielman note, the basis of social 
behavior is one’s willingness to approach another, which is sensitive to anxiety levels. In this 
way, an increase in social behavior may be just one result of a general reduction in anxiety. 
All of the above illustrate the complex nature of OT’s effects on social behavior. Using 
nasal OT as our route of administration does little to simplify the problem, as nasal OT’s route 
into the nervous system has been disputed. The potential benefits of nasal administration of 
peptides were discussed earlier, but the exact route by which nasally administered neuropeptides 
enter the brain has been disputed (for review, see Leng & Ludwig, 2015; Quintana, Alvares, 
Hickie, & Guastella, 2015). The most likely route of access is the olfactory pathway, in which 
molecules reach the OB via olfactory fibers, and then are transferred to brain tissue or 
cerebrospinal fluid (Quintana et al., 2015). Through this pathway, it is theoretically possible that 
nasal OT could reach more centralized brain regions, as the OB has projections to the amygdala 
and the hypothalamus. However, there is question over whether this occurs in rodents and, if so, 
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under what specific circumstances. A neuroimaging study found that nasal OT only activated the 
primary olfactory system, some brain stem regions, and sensory afferents, suggesting that OT 
was not able to penetrate into more centrally located brain regions (Ferris et al., 2015). In 
contrast, a microdialysis study found that nasal OT increased OT levels in the amygdala and 
hippocampus, suggesting that it is indeed reaching central brain regions (Neumann et al., 2013). 
However, the implantation of microdialysis probes causes significant tissue damage, and plasma 
OT may have been unintentionally measured as blood vessels were ruptured.  
This raises the question of how nasal OT has been found to alter social behavior, if it may 
not reach past the OB, brain stem, and sensory afferents. Again, it is important to note the 
interplay of top-down and bottom-up processes. Even if nasal OT is unable to penetrate into 
deeper brain regions, its superficial effects may be sufficient to elicit social behavior changes. Its 
effects on the OB may alter how olfactory stimuli is processed, leading to altered social 
behavior. Indeed, infusion of OT into the OB is sufficient to enhance social recognition (Dluzen, 
Shang, & Landgraf, 2001). 
Beyond the complexity of the OT system, a few factors of our study may have 
contributed to the lack of effect. A significant constraint is our use of normal virgin and 
postpartum animals; it is possible that we encountered a ceiling effect, whereby administering 
OT to a normal OT system had little impact. One next step will be to look at animals with 
disrupted OT systems. For example, postpartum dams treated with cocaine during gestation show 
a number of OT disruptions, including lower levels of OT in various areas of the brain, including 
the VTA (Johns, Lubin, Walker, Meter, & Mason, 1997), and reductions in OT receptor binding 
(Jarrett, McMurray, Walker, & Johns, 2006). These changes may be partly responsible for the 
reduced maternal behavior and increased aggression found in cocaine-exposed dams (Johns, 
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Noonan, & Zimmerman, 1994). If we administer the same experimental procedure to cocaine-
exposed dams and see no effect, it will provide further evidence that nasal OT does not directly 
affect the mesolimbic DA system. However, if an effect is found, it would suggest that a ceiling 
effect was responsible for the results from the present study. 
In addition to the possible ceiling effect of OT, the present study contained some 
methodological limitations. First, we measured evoked DA release by electrically stimulating the 
VTA. Although this provides the benefit of controlling the environment under which each 
measurement is taken, it is in no way a realistic representation of normal brain activity, and the 
relatively large current applied to the VTA may mask more subtle changes that could be 
occurring. Secondly, we used one acute administration of nasal OT, which may not be sufficient 
to elicit noticeable changes, and follow-up experiments may utilize repeated treatments before 
the experiment. 
Pregnancy Affects Stimulated Dopamine Release at Baseline 
When comparing baseline measurements between animal groups, we found significantly 
higher DA concentrations in early postpartum dams compared to virgin animals. This is a 
plausible finding in consideration with other studies examining the role of the DA system in the 
postpartum period. In order to prepare for the onslaught of novel pup-stimuli and the energy-
intensive task of caring for a litter, the peripartum period is rife with changes in the DA system. 
However, the precise changes that occur in this time are still under investigation. Postpartum 
animals have been found to exhibit reductions in 3,4-Dihydroxyphenylacetic acid (DOPAC), a 
metabolite of DA, indicating alterations in DA turnover (Byrnes, Bridges, Scanlan, Babb, & 
Byrnes, 2007; Olazábal, Abercrombie, Rosenblatt, & Morrell, 2004). A similar effect is found 
using in vivo measurements of DA turnover (Afonso, King, Chatterjee, & Fleming, 2009). 
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Similarly, we found a trend toward a reduction in the velocity of DA transporters in postpartum 
dams. Together, these findings suggest that DA is not cleared as readily from the synapse in 
postpartum dams as it is in virgin animals. Additionally, we found that more DA was released 
per pulse of electrical stimulation in postpartum dams. It is unclear why this may be, as little 
research has been performed examining basal DA content in the NAc in the early postpartum 
period. Tissue studies have found similar levels of DA content between virgin animals and 
postpartum dams (Byrnes et al., 2007), but in vivo experiments have revealed lower basal DA 
levels in postpartum dams (Afonso et al., 2009; Afonso, King, Novakov, Burton, & Fleming, 
2011; Afonso et al., 2013). Our findings provide additional information as to how the 
mesolimbic DA system changes in the early postpartum period, and follow-up experiments can 
investigate the exact mechanisms at play. 
Conclusion 
 Although we anticipated a direct excitatory effect of nasal OT on NAc DA release, this 
was not the case, suggesting a more complex relationship between the two systems. However, 
we did find an effect of postpartum status on basal DA release, contributing to the understanding 
of changes in the mesolimbic DA system in the early postpartum period. Further experiments 
using cocaine-treated dams will reveal whether nasal OT exerts a different effect on animals with 
OT disturbances. 
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Figures 
 
Figure 1. Evoked DA at baseline between virgin and postpartum animals. Postpartum animals 
released significantly higher concentrations of DA at baseline to the same electrical stimulation 
compared to virgin animals (p=0.005). The second and third quartiles are represented by dark 
and light gray, respectively. 
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Figure 2. DA released per pulse ([DA]p) and velocity of DA transporters (Vmax) derived from 
electrically evoked DA signals in virgin and postpartum animals. VTA-NAc neurons in 
postpartum animals released significantly more DA per pulse of electrical stimulation than virgin 
animals (p=0.008). The velocity of DA transporters (Vmax) in postpartum animals was reduced 
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compared to virgin animals. This difference, although not statistically significant, was a strong 
trend (p=0.051).  
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Figure 3. Representative color plots (left) and current vs. time traces (right) from a virgin female 
(top) and postpartum dam (bottom). Color plots display changes in current (color) at a range of 
applied potentials (y-axis) over time (x-axis). Inset, DA cyclic voltammogram from respective 
rat. Red bar indicates time of electrical stimulation. 
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Figure 4. Evoked DA concentration as a percent of basal measurements in virgin and postpartum 
rats after nasal treatment of either OT or vehicle. [DA]max was averaged into four 15-minute 
epochs. No differences were observed between groups or over time. 
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